Evidence map›Paper›PMID 37278080›Full record

ArticleUlusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES2023

Clinical outcomes of obstructive colorectal cancer patients during the coronavirus disease 2019 pandemic.

Cemil Burak Kulle, Berke Sengun, Ali Fuat Kaan Gok, Ilker Ozgur, Adem Bayraktar, Cemalettin Ertekin, Alisan Berk Deniz, Metin Keskin

Abstract read
In one paragraph

Article in Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cemil Burak KulleDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Berke SengunDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Ali Fuat Kaan GokDepartment of Surgery, Khoja Akhmet Yassawi International Kazakh-Turkish University School of Medicine, Kazakhstan.
Ilker OzgurDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Adem BayraktarDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Cemalettin ErtekinDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Alisan Berk DenizDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.
Metin KeskinDepartment of General Surgery, Istanbul University, Istanbul Faculty of Medicine, İstanbul-Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic has affected all aspects of clinical care including diagnosis and treatment of colorectal cancers (CRCs) globally, including in Türkiye. During the initial peak of the pandemic, elective surgeries and outpatient clinics were restricted in addition to the government-imposed lockdown, resulting in a decrease in the number of colonoscopies being performed and patients admitted to inpatient wards for treatment of CRCs. In this study, we aimed to investigate whether the pandemic has affected presentation characteristics and outcomes of obstructive colorectal cancer in this period.

methodsThis is a single-center, retrospective cohort study based on all CRC adenocarcinoma patients that underwent surgical resection in a high-volume tertiary referral center in Istanbul, Türkiye. Patients were divided into two groups before and after 15 months of identification of 'patient-zero' in Türkiye (March 18, 2020). Patient demographics, initial presentation characteristics, clin-ical outcomes, and pathological cancer stages were compared.

resultsOverall, 215 patients underwent resection for CRC adenocarcinoma during 30 months (COVID era: 107, pre-COVID era: 108). Patient characteristics, tumor location, and clinical staging were comparable between two groups. During the COVID period, the number of obstructive CRCs (P<0.01) and emergency presentations (P<0.01) increased significantly compared to the respective pre-COVID period. However, there were no differences between 30-day morbidity, mortality, and pathological outcomes (P>0.05).

conclusionAlthough the results of our study indicate a significant increase in emergency presentation and a decrease in elective admissions of CRCs during the pandemic, patients treated during the COVID period were not at a significant disadvantage in terms of post-operative outcomes. Further efforts should be made to decrease risks related to an emergency presentation of CRCs for future adverse events.

Indexed as

AdenocarcinomaColorectal NeoplasmsCOVID-19Communicable Disease ControlHumansPandemicsRetrospective Studies

Identifiers

PMID37278080
PMCPMC10315929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.